Wuppertal, Germany

Klaus-Dieter Ramsch

This inventor holds 4 USPTO granted patents. Top assignee: Bayer Aktiengesellschaft. Active years: 1985-1993.


% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 103(Granted Patents)


Location History:

  • Wuppertal, DE (1985 - 1989)
  • Heerlen, NL (1993)

Company Filing History:


Years Active: 1985-1993

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Klaus-Dieter Ramsch: Innovator in Pharmaceutical Formulations

Introduction

Klaus-Dieter Ramsch is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid medicament formulations. With a total of 4 patents to his name, Ramsch has focused on improving the efficacy and delivery of essential medications.

Latest Patents

Ramsch's latest patents include innovative formulations that enhance the delivery of nifedipine, a medication known for its coronary vasodilator effects. One of his key inventions is directed towards solid pharmaceutical compositions containing nifedipine crystals with a specific surface area of 1.0 to 4.0 m²/g, mixed with a solid diluent. This formulation addresses the deficiencies found in prior art compositions. Another significant patent involves a sprayable liquid formulation that comprises specific components per 100 ml, aimed at improving the administration of dihydropyridine.

Career Highlights

Throughout his career, Ramsch has been associated with Bayer Aktiengesellschaft, a leading global pharmaceutical company. His work has contributed to advancements in drug formulation and delivery systems, making a positive impact on patient care.

Collaborations

Ramsch has collaborated with esteemed colleagues such as Ahmed Hegasy and Roland Rupp, further enhancing the innovative efforts within his field.

Conclusion

Klaus-Dieter Ramsch stands out as a prominent inventor in the pharmaceutical industry, with a focus on improving drug formulations. His contributions continue to influence the development of effective medications that benefit patients worldwide.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…